Test Your Knowledge of Retinal Vascular Disease Research Presented at AAO!
Do you remember the Retinal Vascular Disease research presented at AAO 2024? Test your knowledge now and see how you rank!
Read More
Author: Rebecca Shover
Test Your Knowledge of RCC Research Presented at ESMO!
Do you remember the RCC research presented at ESMO 2024? Test your knowledge now and see how you rank!
Read More
Circulating Plasma Cells Predict Poor Survival in Multiple Myeloma
A recent study evaluated the impact of circulating plasma cells in patients with primary multiple myeloma on bortezomib-containing induction therapy.
Read More
Challenges in Treating Richter Transformation with Novel Agents
A recent study from ASH 2024 examined the clinical features and outcomes of RT in British Columbia, comparing two eras: the chemoimmunotherapy (CIT) era (pre-2016) and the novel agents (NA) era (post-2016).
Read More
Addressing Racial Disparities in Stress and Coping for Indolent Blood Cancers
Educational programs and psychological support addressing cancer-related beliefs and promoting healthier coping strategies are crucial for improving outcomes.
Read More
AAO eBook 2024
A curated eBook featuring AAO 2024 retinal vascular disease-focused studies, findings, and expert opinions.
Read More
CHEST eBook
A curated eBook featuring CHEST 2024 RCC-focused studies, findings, and expert opinions.
Read More
COPD eBook 2024
A curated ebook on COPD featuring recent studies, findings, and opinions from thought leaders.
Read More
Tardive Dyskinesia eBook 2024
A curated ebook on tardive dyskinesia featuring recent studies, findings, and opinions from thought leaders.
Read More
MRD Assessment May Improve Early Intervention for Inflammatory BC Recurrence
Molecular residual disease was detected about six months before radiographic confirmation of recurrence in patients with inflammatory breast cancer.
Read More
A Curious Case of COPD
A 69-year old patient from Southeast Asia presents with a 10-year history of cough and progressive dyspnea. The patient denies tobacco use or exposure.
Read More
SABCS Session Explores Treatment Considerations in Metastatic ER+ Breast Cancer
Oncologist Marla Lipsyc-Sharf, MD, and colleagues will discuss treatment considerations in metastatic ER+ breast cancer at the 2024 SABCS meeting.
Read More
2024 SABCS Meeting: What’s New in Early & Metastatic Breast Cancer?
This roundup includes a selection of abstracts on early and metastatic breast cancer presented at the 2024 San Antonio Breast Cancer Symposium.
Read More
The Latest on Breast Cancer: Research Updates From SABCS
New research on breast cancer was presented at the San Antonio Breast Cancer Symposium 2024, including updates on HER2-enriched disease and lymphedema.
Read More
Will You Be Attending “Case Based Clinical Approach to ER Positive Metastatic Breast Cancer” at SABCS?
Will you be attending “Case Based Clinical Approach to ER Positive Metastatic Breast Cancer” on Wednesday, December 11?
Read More
Will You Be Attending “Mind the Gap — Breast Cancer in the Young” at SABCS?
Will you be attending “Mind the Gap — Breast Cancer in the Young” at SABCS?
Read More
Outcomes, Distinctions in Double-Resistant/Double-Exposed CLL
Treatment resistance and toxicity remain critical challenges in managing chronic lymphocytic leukemia (CLL), according to researchers at the ASH Annual Meeting.
Read More
Financial Toxicity, Adherence, and QOL in Patients With CLL on First-Line Oral Oncolytic Therapy
Oral oncolytic therapies have revolutionized the treatment of chronic lymphocytic leukemia (CLL), offering improved outcomes and convenience for patients.
Read More
Will You Be Attending “Addressing Current Questions and Controversies in the Management of CLL” At ASH?
Will you be attending the morning symposia, “Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia – What Clinicians Want to Know” at ASH?
Read More
ESMO eBook
A curated eBook featuring ESMO 2024 RCC-focused studies, findings, and expert opinions.
Read More